A Study of MRG003 in Patients With Advanced Solid Tumors

Clinical trial NCT04868344 · COMPLETED

Trial details

NCT number: NCT04868344
Sponsor: Shanghai Miracogen Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2018-05-09
Primary completion: 2021-03-29
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.